Market Scenario:
Spina bifida is a congenital disorder that results in the
malformation of the spinal cord. The condition is more common among Hispanics
and whites, and the prevalence females are more likely to get affected than
males.
On considering historical prevalence data of spina bifida in
northeast China, during 2006-2015, it is found that a total of 2,029 cases of
spina bifida were identified from 3,248,954 live births i.e. 6.25/10,000 live
births. The disease is found to be highly prevalent in Chaoyang, Fuxin, and
Huludao cities of China. According to the 2013 study conducted by Healthcare
Cost and Utilization Project, hospitalization cost related to spina bifida was
more than USD 600 million in 2013 for people of all ages.
Get
Exclusive Sample Report @
https://www.marketresearchfuture.com/sample_request/5643
Segmentation
The global spina bifida market is segmented on the basis of
type, diagnosis, treatment, and end user.
On the basis of the type, the market is classified as
occulta, closed neural tube defects, meningocele, and myelomeningocele.
On the basis of the diagnosis, the market is classified as
blood tests, ultrasound, amniocentesis, and others. The blood tests segment is
further classified as maternal serum alpha-fetoprotein (MSAFP) test, test to
confirm high AFP levels, and other blood tests.
Intended
Audience
·
Pharmaceutical Companies
·
Medical Device Companies
·
Research and Development (R&D) Companies
·
Diagnostic Laboratories
·
Government Research Institute
·
Academic Institutes and Universities
Regional
Analysis
The Americas dominate the spina bifida market owing to the
rising occurrence of spina bifida in this region, and technological
advancements. According to the statistics suggested by Centers for Disease
Control and Prevention (CDC), around 1,500 babies are born with spina bifida
every year in the United States. It is also reported that Hispanic women are
the most vulnerable population for this disease as compared to non-Hispanic
black or non-Hispanic white women.
Asia Pacific is the fastest growing spina bifida market owing
to a huge patient pool and development in healthcare technology. Healthcare
expenditure is found to be improving in various Asia Pacific regions. According
to the data suggested by Australian Institute of Health and Welfare during the year
2015-16, the total health expenditure was USD 170.4 billion i.e. 3.6% higher
than the expenditure of 2014-2015.
The Middle East & Africa holds the lowest share of the
global market due to low development, lack of technical knowledge, and poor
medical facilities.
Key Players
Some of key the players in the global spina bifida market are
B. Braun Melsungen AG, Boston Scientific, C.B. Fleet, C.R. Bard, Inc.,
Coloplast A/S, ConvaTec Group plc, Cook Medical, Covidien Private Ltd., Dynarex
Corporation, Ethicon, Fujifilm, Hollister Incorporated, KARL STORZ, Medline
Industries, Medtronic plc, Olympus, Pacific Hospital Supply Co., Ltd., Smith
& Nephew, Stryker, Teleflex Incorporation, Wellspect Healthcare, and
others.
Get Your
Customized Report @ https://www.marketresearchfuture.com/reports/spina-bifida-market-5643
Table of
Content:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
TOC
Continued…!
Get
Discount @https://www.marketresearchfuture.com/check-discount/5643
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
No comments:
Post a Comment